DNAprint Genomics (DNAG)

[SlopsterSlasher]

There is little current competition in the initial niches that DNAPrint has selected to compete. At present DNAPrint is the only company in the world with IP for operating Admixture Mapping screens, and DNAPrint believes that the use of AIMs is crucial for the development of tests for complex, common traits (such as drug response) that meet expected clinical performance criteria.
[From the 10k filing}